Nuclear factor ?B mutations in human subjects: The devil is in the details - 05/10/18

Key words : NFKB1, nuclear factor κB signaling, primary immunodeficiency disease, common variable immunodeficiency
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: B. Grimbacher has received research funding from the German Ministry of Education and Research (grant no. 01E01303 and E:med/sysINFLAME grant no. 01ZX1306F), the E-rare program of the European Commission EURO-CMC (01GM1502), the German Center for Infection Research DZIF, the Deutsche Forschungsgemeinschaft (SFB1160-IMPATH), Bristol-Myers Squibb, CSL Behring, Novartis, and Baxalta, and over the last 3 years, he has received lecture honoraria from CSL-Behring, Baxalta, and Biotest. M. Fliegauf declares that he has no relevant conflicts of interest. |
Vol 142 - N° 4
P. 1062-1065 - octobre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
